Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, Others), By Treatment (Anti-Allergy Medications v/s Immunotherapy), By Route of Administration (Oral, Inhalers, Intranasal, Others), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F

Market Overview

The Global Allergy Treatment Market was valued at USD 23.14 billion in 2024 and is expected to reach USD 36.24 billion by 2030 with a CAGR of 7.76% during the forecast period. The global market for Allergy Treatment is experiencing significant growth, driven by the growing prevalence of different kinds of allergies among population across the globe. According to a report published by Food Allergy Research & Education in 2020, estimated that around 32 million residents in the United States have food allergies. Additionally, growing use of over-the-counter medications and increasing popularity of self-medication is further expected to create lucrative opportunities for the growth of global allergy treatment market. Besides, growing popularity of immunotherapy for the treatment of different allergies is further expected to support market growth. Furthermore, growing geriatric population across the globe is expected to increase the demand for different allergy treatments. Elderly population has weaker immune system and are more susceptible to different kinds of allergies, thereby increasing the demand for different treatment options for treatment of various allergies.

Key Market Drivers

Increasing Prevalence of Allergic Diseases Worldwide

Allergies have become one of the most common chronic health conditions across the globe. Seasonal allergies, asthma, eczema, and food-related allergies are now widely reported among both children and adults. According to recent government health statistics, nearly one-third of adults in the United States reported some type of allergy in 2021, with seasonal allergies being the most common. Globally, asthma alone affected over 260 million people in 2019, highlighting the massive number of individuals requiring regular care.

This rising burden creates a strong demand for effective treatments ranging from over-the-counter medications such as antihistamines to advanced therapies including immunotherapy and biologics. Allergies also place a heavy economic cost on families and healthcare systems due to frequent doctor visits, lost work productivity, and reduced quality of life. As a result, governments, hospitals, and pharmaceutical companies are investing more in allergy care to meet this growing need. The increasing awareness among patients, availability of better diagnostic methods, and improvements in healthcare infrastructure all contribute to the continuous growth of the allergy treatment market.

Environmental Changes and Lifestyle Factors Increasing Allergy Cases

Environmental and lifestyle changes are another major factor behind the growth of allergies worldwide. Rapid urbanization, industrialization, and climate change have increased exposure to air pollution and altered pollen seasons. Government agencies monitoring climate and health have reported that warmer temperatures and rising pollution levels extend pollen seasons, making allergic conditions worse and more common. For example, in Europe, pollen allergy is now reported in a large share of the population, and climate changes are further intensifying the problem.

Urban residents are particularly affected because pollutants such as particulate matter and nitrogen oxides combine with allergens to trigger stronger reactions. This has led to more cases of asthma, allergic rhinitis, and other respiratory issues. In addition, modern lifestyle habits, reduced outdoor activity, and dietary changes have also been linked to increased allergic sensitivity in both adults and children. These environmental and lifestyle shifts are pushing more people to seek medical care, driving demand for medications, allergy testing, and long-term management solutions.

Download Free Sample Report

Key Market Challenges

Unequal Access to Allergy Care Across Regions

Despite the growing need for allergy treatment, access to quality care remains uneven across the world. In developed countries, patients often have access to advanced diagnostic tests, specialized doctors, and the latest therapies, including biologics and immunotherapies. However, in many low- and middle-income nations, there is a shortage of allergy specialists, limited diagnostic facilities, and fewer treatment options available.

This creates a large gap where millions of patients remain untreated or rely only on basic over-the-counter medicines. High costs of advanced therapies also make them unaffordable for a large section of the global population. The result is a two-tiered system: advanced and effective care in high-income regions and limited or outdated options in resource-constrained areas. This inequality not only slows down overall market growth but also increases the global disease burden, as untreated patients face frequent complications and reduced quality of life.

Limited Long-Term Data on New Allergy Treatments

Another major challenge in the allergy treatment market is the lack of long-term data on the safety, effectiveness, and value of newer therapies. While biologics and immunotherapies have shown great promise in clinical trials, health authorities and insurance providers often require long-term evidence before approving widespread use and coverage. Many countries face uncertainty about how cost-effective these treatments are over a patient’s lifetime compared to traditional options like steroids and antihistamines. In addition, healthcare guidelines vary widely between regions, with some countries adopting new treatments quickly while others continue to rely on older protocols. This inconsistency creates confusion for patients and doctors and slows the overall adoption of innovative therapies. Without strong real-world evidence and consistent global standards, many patients may not benefit from the most advanced treatments, and companies may face hurdles in expanding their allergy care solutions worldwide.

Key Market Trends

Rise of Biologics and Precision Medicine for Allergy Care

One of the most important trends shaping the allergy treatment market is the growing use of biologics and precision medicine. Biologics are targeted therapies designed to block specific pathways in the immune system that cause severe allergic reactions and asthma. In recent years, government health authorities have approved several biologics for conditions like severe asthma, atopic dermatitis, and chronic hives. These therapies are particularly beneficial for patients who do not respond to conventional treatments.

Alongside biologics, precision medicine is gaining importance, with doctors using diagnostic tests and biomarkers to tailor treatment plans for individual patients. This approach ensures that patients receive therapies that are most effective for their specific type of allergy. While biologics are currently expensive, their ability to significantly improve quality of life and reduce hospitalizations makes them an attractive option. Over time, as more competition enters the market and health systems expand coverage, biologics are expected to become a standard part of allergy care.

Growing Use of Immunotherapy, Digital Health, and Preventive Measures

Another major trend is the shift towards long-term management and prevention of allergies. Immunotherapy, which involves gradually exposing patients to allergens to reduce sensitivity, is gaining acceptance worldwide as the only approach capable of changing the natural course of allergic disease. Both subcutaneous (injections) and sublingual (tablets or drops) immunotherapy options are expanding in availability.

In addition, digital health tools such as mobile apps for symptom tracking, pollen forecasts, and telemedicine consultations are becoming popular among patients and doctors. These tools improve disease monitoring, patient engagement, and treatment adherence. At the same time, governments are introducing stronger environmental and public health measures, such as air quality improvements, urban planning for allergenic plants, and awareness campaigns about allergy prevention. Together, these developments are shaping a more comprehensive approach to allergy care that goes beyond short-term symptom relief.

Segmental Insights

Type Insights

Based on Type, Asthma accounts for the largest share of the global allergy treatment market. This dominance is mainly due to its widespread prevalence, chronic nature, and the high healthcare burden associated with it. According to the World Health Organization (WHO), asthma affected around 262 million people worldwide in 2019 and caused nearly half a million deaths annually. Unlike some seasonal or mild allergies, asthma is a long-term condition that requires ongoing treatment, regular medical supervision, and, in many cases, emergency care during severe attacks. The need for continuous management drives strong demand for medications such as inhaled corticosteroids, bronchodilators, leukotriene modifiers, and biologic therapies. Additionally, government health surveys in developed regions like North America show that asthma remains one of the most common chronic conditions among children and adults, further increasing the number of patients who require treatment throughout their lives.

Download Free Sample Report

Regional Insights

Based on the region, North America currently holds the largest share of the global allergy treatment market. Several factors contribute to this dominance. Firstly, the region reports one of the highest prevalence rates of allergic conditions in the world. According to the U.S. Centers for Disease Control and Prevention (CDC), about one in three adults in the United States suffer from some form of allergy, with seasonal allergies, asthma, and food allergies being the most common. The high number of affected individuals drives continuous demand for medications, diagnostic testing, and long-term management solutions. Secondly, the presence of advanced healthcare infrastructure, well-established allergy specialists, and wide availability of diagnostic centers allows for faster adoption of new treatments. The United States and Canada also have favorable regulatory frameworks that support the introduction of innovative therapies such as biologics and advanced immunotherapies. Furthermore, high health insurance coverage and greater healthcare spending per capita make advanced treatment options more accessible to patients in this region compared to other parts of the world.

Recent Developments

• In June 2025, Sanofi acquired Blueprint Medicines for USD 9.1 billion, adding Ayvakit and early-stage immunology assets.
• In April 2025, ALK-Abbello secured European approval for pediatric use of Itulazax tree-pollen SLIT tablet, aligning with the 2025/2026 season.

Key Market Players

• Johnson & Johnson
• Sanofi SA
• GlaxoSmithKline plc.
• F. Hoffmann-La Roche AG
• Leti Pharma GmbH
• AbbVie Inc.
• Alembic Pharmaceuticals Limited
• Bausch Health Companies Inc.
• Novartis AG
• ALK-Abello AS

Report Scope:

In this report, the Global Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Allergy Treatment Market, By Type:

o   Eye Allergy

o   Food Allergy

o   Skin Allergy

o   Asthma

o   Rhinitis

o   Others

• Allergy Treatment Market, By Treatment:

o   Anti-Allergy Medications

o   Immunotherapy

• Allergy Treatment Market, By Route of Administration:

o   Oral

o   Inhalers

o   Intranasal

o   Others

• Allergy Treatment Market, By Distribution Channel:

o   Hospital Pharmacies

o   Retail Pharmacies

o   Online Pharmacies

• Allergy Treatment Market, By Region:

o   North America

§  United States

§  Mexico

§  Canada

o   Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  India

§  South Korea

§  Japan

§  Australia

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East and Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Allergy Treatment Market.

Available Customizations:

Global Allergy Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Allergy Treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]